Medtronic PLC
NYSE:MDT
Medtronic PLC
Operating Income
Medtronic PLC
Operating Income Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Operating Income | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
|
Medtronic PLC
NYSE:MDT
|
Operating Income
$6.5B
|
CAGR 3-Years
-3%
|
CAGR 5-Years
-2%
|
CAGR 10-Years
2%
|
|
|
STERIS plc
NYSE:STE
|
Operating Income
$959m
|
CAGR 3-Years
26%
|
CAGR 5-Years
13%
|
CAGR 10-Years
15%
|
|
Medtronic PLC
Glance View
In the intricate world of medical technology, Medtronic PLC stands tall as one of the foremost innovators transforming the landscape of healthcare. Founded in 1949 as a humble medical supply repair shop in Minnesota, Medtronic has grown into a global titan, driven by the enduring mission to alleviate pain, restore health, and extend life. The company's breadth is vast, touching nearly every aspect of patient care, from advanced robotic-assisted surgery systems to sophisticated insulin pumps. At its core, Medtronic thrives on relentless research and development, continually bridging the gap between cutting-edge technology and practical medical solutions. By forging deep alliances with healthcare providers and systems around the globe, the company ensures its innovations are not only groundbreaking but also widely accessible. The company's financial engine purrs to life primarily through the development and sale of medical devices across four major segments: Cardiac and Vascular Group, Minimally Invasive Therapies, Restorative Therapies Group, and Diabetes Group. Each unit meticulously focuses on innovating and providing solutions relevant to its field, ensuring a diversified portfolio with robust pipelines. For instance, within the Cardiac and Vascular Group, Medtronic supplies life-saving products like pacemakers and stents while also exploring breakthrough therapies such as transcatheter heart valves. By capitalizing on a global presence, the company strategically taps into both mature markets in North America and Europe and emerging markets across Asia and Latin America, thereby driving substantial revenue streams. Through this multifaceted operational framework, Medtronic not only sustains its market dominance but also reinvests in the future of medical technology, symbolizing a perpetual cycle of growth and innovation.
See Also
What is Medtronic PLC's Operating Income?
Operating Income
6.5B
USD
Based on the financial report for Jan 24, 2025, Medtronic PLC's Operating Income amounts to 6.5B USD.
What is Medtronic PLC's Operating Income growth rate?
Operating Income CAGR 10Y
2%
Over the last year, the Operating Income growth was 0%. The average annual Operating Income growth rates for Medtronic PLC have been -3% over the past three years , -2% over the past five years , and 2% over the past ten years .
You don't have any saved screeners yet